Ibex Medical Analytics, an artificial intelligence-powered cancer diagnostics, raised $55 million in series C financing.
Ibex’s Galen platform integrates AI into pathologists’ workflows. The platform has gone live at Pittsburgh-based UPMC, according to Becker’s. The Israeli company will use the funding to expand further into the U.S.
Venture capital firm 83North led the funding round. The financing brought Ibex’s total capital raised to over $100 million.
